Additional tiotropium inhaler available to prescribe

By Chloe Harman on the 22 October 2021

Acopair is delivered by the dry powder NeumoHaler device.

Acopair (tiotropium) is a new option for patients with COPD. | VIATRIS

Acopair (tiotropium) 18 microgram capsules are indicated as a maintenance bronchodilator treatment to relieve symptoms of patients with chronic obstructive pulmonary disease (COPD).

Further information

View Acopair drug record Summary of Product Characteristics Manufacturer: Mylan

Single-use

The NeumoHaler is a single-dose inhalation device with a green body and cap and a white push button made from plastic and stainless steel. A new inhaler is supplied with each prescription of 30 or 60 capsules.

Acopair is the fourth dry powder tiotropium inhaler available in the UK, in addition to Spiriva HandiHaler, Braltus and Tiogiva.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

The most up-to-date drug information at your fingertips.

  • Get the prescribing support you need.
  • Register today for full access to the MIMS database, plus tables and guideline summaries, new and deleted products and consultation tools.
Register Now
Already Registered?

Forgotten password?